Page last updated: 2024-10-31

mirtazapine and Teratoma

mirtazapine has been researched along with Teratoma in 1 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Teratoma: A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, W1
Yang, H1
Piao, Y1
Quan, M1
Guo, D1

Other Studies

1 other study available for mirtazapine and Teratoma

ArticleYear
Progressive multifocal leukoencephalopathy in a patient with mediastinal teratoma: a case report.
    BMC neurology, 2022, Jan-27, Volume: 22, Issue:1

    Topics: Aged; Brain; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mirtazapine; Ter

2022